This role is for a recognized expert to spearhead the advancement of innovative IHC methodologies specifically for non-clinical radioconjugate discovery projects in oncology within AstraZeneca
Job Summary
This role is for a recognized expert to spearhead the advancement of innovative IHC methodologies specifically for non-clinical radioconjugate discovery projects in oncology within AstraZeneca.
A key focus will be driving the integration and implementation of cutting-edge IHC technologies, multiplexing strategies, and digital pathology solutions to enhance target validation, pharmacodynamics, and biomarker discovery.
This new role within RC Discovery Biology involves building and leading a small team.
Matching Summary
This role is for a recognized expert to spearhead the advancement of innovative IHC methodologies specifically for non-clinical radioconjugate discovery projects in oncology within AstraZeneca.
Salary
Base: 131,201.60 - 172,202.10; Bonus/Equity: Annual Variable Pay Bonus/Short Term Incentive opportunity and potential equity-based long-term incentive program; Benefits: Flex Benefits & Retirement Savings Program, 4 weeks’ paid vacation, annual Personal Days
Skills & Requirements
Must-have
advanced IHC methodologies
non-clinical radioconjugate discovery
target validation
pharmacodynamics
biomarker discovery
digital pathology solutions
Nice-to-have
cutting-edge science
breakthrough science
meaningful outcomes for patients
collaborative, innovative culture
Key Requirements
Master's degree in relevant discipline
Significant experience in Immunohistochemistry (IHC) and histopathology
Assay development, optimization, validation
Digital pathology
Quantitative image analysis
Drug discovery or translational research setting
Proven understanding of molecular and cellular biology